{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:59:24Z","timestamp":1772121564666,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.rcsop.2025.100561","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:04:41Z","timestamp":1736165081000},"page":"100561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry"],"prefix":"10.1016","volume":"17","author":[{"given":"Jason S.","family":"Chladek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.rcsop.2025.100561_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.JAA.0000545072.09344.ee","article-title":"Opioid use disorder: a public health emergency","volume":"31","author":"Alexander","year":"2018","journal-title":"JAAPA"},{"key":"10.1016\/j.rcsop.2025.100561_bb0010","series-title":"Opioid Addiction","author":"Azadfard","year":"2023"},{"key":"10.1016\/j.rcsop.2025.100561_bb0015","author":"American Psychiatric Association"},{"key":"10.1016\/j.rcsop.2025.100561_bb0020","author":"Wisconsin Department of Health Services"},{"key":"10.1016\/j.rcsop.2025.100561_bb0025","author":"Wisconsin Department of Health Services"},{"key":"10.1016\/j.rcsop.2025.100561_bb0030","author":"Wisconsin Department of Corrections"},{"key":"10.1016\/j.rcsop.2025.100561_bb0035","series-title":"Medications for substance use disorders","author":"Substance Abuse and Mental Health Services","year":"2024"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100561_bb0040","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/add.13779","article-title":"Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England","volume":"112","author":"Marsden","year":"2017","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.rcsop.2025.100561_bb0045","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.rcsop.2025.100561_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20133","key":"10.1016\/j.rcsop.2025.100561_bb0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100561_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ADM.0000000000000381","article-title":"Feasibility and effectiveness of continuing methadone maintenance treatment during incarceration compared with forced withdrawal","volume":"12","author":"Moore","year":"2018","journal-title":"J Addict Med"},{"key":"10.1016\/j.rcsop.2025.100561_bb0065","author":"Maruschak"},{"key":"10.1016\/j.rcsop.2025.100561_bb0070","author":"Wisconsin Department of Health Services & Wisconsin Department of Corrections"},{"key":"10.1016\/j.rcsop.2025.100561_bb0075","author":"Substance Abuse and Mental Health Services"},{"key":"10.1016\/j.rcsop.2025.100561_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108849","article-title":"Racial\/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US","volume":"226","author":"Stahler","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2025.100561_bb0085","series-title":"Health care transitions for individuals returning to the community from a public institution: promising practices identified by the Medicaid reentry stakeholder group","author":"Office of the Assistant Secretary for Planning and Evaluation","year":"2024"},{"key":"10.1016\/j.rcsop.2025.100561_bb0090","doi-asserted-by":"crossref","first-page":"1377193","DOI":"10.3389\/fpubh.2024.1377193","article-title":"Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review","volume":"12","author":"Chladek","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.rcsop.2025.100561_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.rcsop.2025.100561_bb0100","doi-asserted-by":"crossref","unstructured":"Look KA, Dekeyser C, Conjurske S, et al. Illustrating access to community pharmacies in Wisconsin. J Am Pharm Assoc (2003). 2021;61(4):492\u2013499. doi:https:\/\/doi.org\/10.1016\/j.japh.2021.02.004.","DOI":"10.1016\/j.japh.2021.02.004"},{"key":"10.1016\/j.rcsop.2025.100561_bb0105","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100561_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/pharmacy7020059","article-title":"Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin","volume":"7","author":"Ford","year":"2019","journal-title":"Pharmacy (Basel)"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100561_bb0115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/add.14946","article-title":"Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis","volume":"115","author":"Bahji","year":"2020","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0120","first-page":"54","article-title":"Anticipated barriers to sustained engagement in treatment with medications for opioid use disorder after release from incarceration","volume":"17","author":"Kaplowitz","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.rcsop.2025.100561_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: a systematic review from the client perspective","volume":"221","author":"Hall","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13722-019-0166-0","article-title":"Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail","volume":"14","author":"Velasquez","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addict Sci Clin Pract"},{"issue":"16","key":"10.1016\/j.rcsop.2025.100561_bb0140","article-title":"\u201cJust fighting for my life to stay alive\u201d: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories","volume":"18","author":"Hoffman","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.rcsop.2025.100561_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addbeh.2019.01.020","article-title":"Challenges on the road to recovery: exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City","volume":"93","author":"Truong","year":"2019","journal-title":"Addict Behav"},{"key":"10.1016\/j.rcsop.2025.100561_bb0150","article-title":"Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia","author":"Staton","year":"2023","journal-title":"J Community Psychol"},{"key":"10.1016\/j.rcsop.2025.100561_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105766","article-title":"Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program","volume":"128","author":"Martin","year":"2019","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13722-018-0124-2","article-title":"Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach","volume":"13","author":"Bunting","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.rcsop.2025.100561_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103803","article-title":"Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers","volume":"110","author":"Stopka","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.rcsop.2025.100561_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103823","article-title":"Jail-based reentry programming to support continued treatment with medications for opioid use disorder: qualitative perspectives and experiences among jail staff in Massachusetts","volume":"109","author":"Matsumoto","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.rcsop.2025.100561_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108338","article-title":"Access to treatment for pregnant incarcerated people with opioid use disorder: perspectives from community opioid treatment providers","volume":"126","author":"King","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100561_bb0180","first-page":"295","article-title":"Breadth of the socio-ecological model","volume":"22","author":"Rn","year":"2017","journal-title":"J Agromedicine"},{"key":"10.1016\/j.rcsop.2025.100561_bb0185","author":"American College Health Association"},{"key":"10.1016\/j.rcsop.2025.100561_bb0190","author":"Center for Disease Control and Prevention"},{"issue":"19","key":"10.1016\/j.rcsop.2025.100561_bb0195","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.3390\/su141912083","article-title":"A tale of two urgent food system challenges: comparative analysis of approaches to reduce high-meat diets and wasted food as covered in U.S. Newspapers","volume":"14","author":"Fry","year":"2022","journal-title":"Sustainability"},{"key":"10.1016\/j.rcsop.2025.100561_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.884678","article-title":"A socio-ecological framework for Cancer prevention in low and middle-income countries","volume":"10","author":"Akinyemiju","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12913-023-09203-2","article-title":"Facilitators and barriers to the delivery of palliative care to patients with Parkinson\u2019s disease: a qualitative study of the perceptions and experiences of stakeholders using the socio-ecological model","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100561_bb0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jftr.12440","article-title":"Engaging parents in preventive programs for adolescent mental health: a socio-ecological framework","volume":"13","author":"Finan","year":"2021","journal-title":"J Fam Theory Rev"},{"key":"10.1016\/j.rcsop.2025.100561_bb0215","doi-asserted-by":"crossref","first-page":"1148758","DOI":"10.3389\/fpubh.2023.1148758","article-title":"Socio-ecological determinants of older people\u2019s mental health and well-being during COVID-19: a qualitative analysis within the Irish context","volume":"11","author":"Guzman","year":"2023","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.rcsop.2025.100561_bb0220","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1111\/jan.15684","article-title":"Housing instability: exploring socioecological influences on the health of birthing people","volume":"79","author":"Robinson","year":"2023","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.rcsop.2025.100561_bb0225","article-title":"Socio-ecological barriers to access COVID-19 vaccination among Burmese irregular migrant workers in Thailand","volume":"8","author":"Khai","year":"2023","journal-title":"J Migr Health"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/heq.2020.0138","article-title":"Barriers and facilitators to accessing health Services for People without Documentation Status in an anti-immigrant era: a socioecological model","volume":"5","author":"Alwan","year":"2021","journal-title":"Health Equity"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100561_bb0235","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.3390\/ijerph18084138","article-title":"Social-ecological barriers to access to healthcare for adolescents: a scoping review","volume":"18","author":"Garney","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"10.1016\/j.rcsop.2025.100561_bb0240","doi-asserted-by":"crossref","first-page":"e0243106","DOI":"10.1371\/journal.pone.0243106","article-title":"Violence and hepatitis C transmission in prison-A modified social ecological model","volume":"15","author":"Sazzad","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.rcsop.2025.100561_bb0245","author":"Lumivero"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"Elo","year":"2008","journal-title":"J Adv Nurs"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100561_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12913-018-2915-2","article-title":"Application of four-dimension criteria to assess rigour of qualitative research in emergency medicine","volume":"18","author":"Forero","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rcsop.2025.100561_bb0260","author":"National Alliance of State Pharmacy Associations"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:53:04Z","timestamp":1741107184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"alternative-id":["S2667276625000022"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100561","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.13.24313637","asserted-by":"object"}]},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100561"}}